<DOC>
	<DOCNO>NCT01771250</DOCNO>
	<brief_summary>This study two part . Each participant receive daily injection LY2605541 one treatment period daily injection insulin glargine treatment period . Each treatment period 3 4 week follow procedure look body us store fat take study drug .</brief_summary>
	<brief_title>A Study LY2605541 Glargine Fats Participants With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 1 diabetic 1 year glycated hemoglobin ( HbA1c ) less 8.5 % Otherwise fit healthy Non smoker Taking medication supplement insulin control diabetes . Suffered hypoglycemic event last 12 month require hospitalization poor awareness hypoglycemia Taking fibrates , thyroid replacement therapy , testosterone , beta blocker systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>